Related Entities
[Video Profile] Ray Krause, CEO of GlucoLight
10 articles also mentioned GlucoLight
GlucoLight Unveils Ergonomic Improvements and Performance Enhancements ...
6 articles also mentioned Ray Krauss
GlucoLight Awarded Patent for Tissue Oximetry Measurement Technology
1 articles also mentioned Matthew J. Schurman
-
Mentioned In 10 Articles
-
Optical Coherence Tomography-Based Continuous Noninvasive Glucose Monitoring in Patients with Diabetes
Mary Ann Liebert, Inc. (May 14 2008) Glucose Explore Article
...betes had blood glucose concentrations evaluated using simultaneous capillary and OCT-based device (Sentris-100^ , GlucoLight, Bethlehem, PA) measurements. Subjects received a 50-g carbohydrate load at the start... (Read Full Article)
Comment on Article Mentions: GlucoLight Glucolight Sentris-100
-
Optical coherence tomography-based continuous noninvasive glucose monitoring in patients with diabetes.
NCBI HomePage (May 14 2008) Glucose Explore Article
...betes had blood glucose concentrations evaluated using simultaneous capillary and OCT-based device (Sentris-100(), GlucoLight, Bethlehem, PA) measurements. Subjects received a 50-g carbohydrate load at the start... (Read Full Article)
Comment on Article Mentions: GlucoLight Glucolight Sentris-100
-
GlucoLight Awarded Patent for Tissue Oximetry Measurement Technology
-- Front | www.centredaily.com (Apr 25 2008) Glucose Explore Article
...also used to develop non-invasive, continuous glucose measurement technology, and its first product SENTRIS-100(TM). The oxygenation of blood perfused tissue is measured by shining light into the perfused tissue... (Read Full Article)
Comment on Article Mentions: GlucoLight Ray Krauss Matthew J. Schurman
-
GlucoLight Awarded Patent for Tissue Oximetry Measurement Technology
businesswire.com (Apr 25 2008) Glucose Explore Article
...also used to develop non-invasive, continuous glucose measurement technology, and its first product SENTRIS-100™. The oxygenation of blood perfused tissue is measured by shining light into the perfused tissue ... (Read Full Article)
Comment on Article Mentions: GlucoLight Glucolight Sentris-100
-
GlucoLight Awarded Patent for Tissue Oximetry Measurement Technology
Free Services for PR (Apr 25 2008) Glucose Explore Article
...also used to develop non-invasive, continuous glucose measurement technology, and its first product SENTRIS-100(TM). The oxygenation of blood perfused tissue is measured by shining light into the perfused tissue... (Read Full Article)
Comment on Article Mentions: GlucoLight Ray Krauss Glucolight Sentris-100
-
GlucoLight Corporation Raises Third Tranche Of ''c'' Round Financing
businesswire.com (Mar 18 2008) Glucose , Funding Explore Article
...ill help us complete our next round of clinical trials expected in May 2008, as we look to complete SENTRIS-100 for the hospital environment. It also assists us with the continued development of SENTRIS-100 for consumer and everyday use, efforts that began early this year.” The GlucoLight SENTRIS-100 monitor requires regulatory clearance and is not yet commercially available. About GlucoLight Corpo... (Read Full Article)
Comment on Article Mentions: GlucoLight Ray Krauss Glucolight Sentris-100
-
GlucoLight Corporation Raises Second Tranche of “c” Round Financing
businesswire.com (Feb 14 2008) Glucose , Funding Explore Article
...oth healthcare professionals and for patients living with diabetes everyday. We’re confident that SENTRIS-100 and its core technology will make this dream a reality.” The GlucoLight SENTRIS-100 monitor requires regulatory clearance and is not yet commercially available. About GlucoLight Corpo... (Read Full Article)
Comment on Article Mentions: GlucoLight Ray Krauss Glucolight Sentris-100
-
GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing
businesswire.com (Feb 14 2008) Glucose , Funding Explore Article
...oth healthcare professionals and for patients living with diabetes everyday. We’re confident that SENTRIS-100 and its core technology will make this dream a reality.” The GlucoLight SENTRIS-100 monitor requires regulatory clearance and is not yet commercially available. About GlucoLight Corpo... (Read Full Article)
Comment on Article Mentions: GlucoLight Ray Krauss Glucolight Sentris-100
-
GlucoLight Unveils Ergonomic Improvements and Performance Enhancements ...
Free Services for PR (Dec 18 2007) Glucose Explore Article
...w: www.gregoryfca.com/mcd/gl1.tif www.gregoryfca.com/mcd/gl2.tif www.gregoryfca.com/mcd/gl3.tif The GlucoLight SENTRIS-100 monitor requires regulatory clearance and is not yet commercially available. About GlucoLight Corpo... (Read Full Article)
Comment on Article Mentions: GlucoLight Ray Krauss Glucolight Sentris-100
-
[Video Profile] Ray Krause, CEO of GlucoLight
onemedplace.com (Dec 17 2007) Glucose Explore Article
... non-invasive medical monitoring products using Optical Coherence Tomography (OCT). The company’s SENTRIS-100 is ... Blood glucose levels have been called the next vital sign in the surgical environment. Numer... (Read Full Article)
Comment on Article Mentions: GlucoLight Glucolight Sentris-100






Recent Comments
Eric Swanson » The Evolution of Spectral Domain OCT
For more information see http://octnews.hivefire.com/entity/profile/oct-information-on-ophthalmology-website/
bernie » Morphology and Epidermal Thickness of Normal Skin Imaged by Optical Coherence Tomography.
Interesting
See all recent comments